TrialPanorama/TrialPanorama-database huggingface dataset:
Study NCT00573716 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT02751177 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT02751177 — Predictive Biomarker (PRD): NRAS mRNA
Genes: NRAS; HRAS1
Study NCT02751177 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT02751177 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT02751177 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Plasma DNA
Study NCT04442256 — Safety Biomarker (SAF): Argininosuccinate synthase
Genes: ASS1; ASS
Study NCT01804712 — Predictive Biomarker (PRD): CXCL13 mRNA
Genes: CXCL13; BCA1; BLC; SCYB13
Study NCT02081638 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT01581632 — Predictive Biomarker (PRD): PLA2G1B mRNA
Genes: PLA2G1B; PLA2; PLA2A; PPLA2
Study NCT01845584 — Predictive Biomarker (PRD): Anti-aquaporin-4 antibody
Study NCT03112525 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study NCT00334581 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00098111 — Safety Biomarker (SAF): Thiopurine S-methyltransferase
Genes: TPMT
Study NCT04547114 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT01266213 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT01266213 — Predictive Biomarker (PRD): GNRH1 mRNA
Genes: GNRH1; GNRH; GRH; LHRH
Study NCT02740543 — Predictive Biomarker (PRD): TSLP mRNA
Genes: TSLP
Study NCT01391598 — Safety Biomarker (SAF): Interleukin 1
Study NCT01391598 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT03689556 — Predictive Biomarker (PRD): FLT1 mRNA
Genes: FLT1; FLT; FRT; VEGFR1
Study NCT01233336 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Hepatocyte growth factor
Genes: HGF; HPTA
Study NCT02167256 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase ABL1
Genes: ABL1; ABL; JTK7
Study NCT00003002 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT00003002 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT01617603 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02078102 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT00642148 — Safety Biomarker (SAF): Myeloperoxidase
Genes: MPO
Study NCT00885638 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study NCT01780519 — Predictive Biomarker (PRD): TOMM40 mRNA
Genes: TOMM40; C19orf1; PEREC1; TOM40
Study NCT04213898 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04213898 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT04213898 — Surrogate Endpoint (SUR): Pathological complete response
Study NCT02134457 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT02134457 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT01493219 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Neutrophil gelatinase-associated lipocalin
Genes: LCN2; HNL; NGAL
Study NCT01125969 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03945981 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT03719469 — Safety Biomarker (SAF): miR-146a
Genes: MIR146A
Study NCT02239731 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT03984500 — Predictive Biomarker (PRD): SCT mRNA
Genes: SCT
Study NCT02530424 — Predictive Biomarker (PRD): CDK4 mRNA
Genes: CDK4
Study NCT02530424 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04265040 — Predictive Biomarker (PRD): MATN1 mRNA
Genes: MATN1; CMP; CRTM
Study NCT02436408 — Predictive Biomarker (PRD): SMO mRNA
Genes: SMO; SMOH
Study NCT01427088 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study NCT01427088 — Safety Biomarker (SAF): BDNF
Study NCT04416607 — Predictive Biomarker (PRD): AMH mRNA
Genes: AMH; MIF
Study NCT01515969 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT01515969 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT01515969 — Pharmacodynamic Biomarker (PDY): Fibroblast growth factor receptor
Study NCT04685304 — Safety Biomarker (SAF): Cytochrome P450 2D6
Genes: CYP2D6; CYP2DL1
Study NCT03179085 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01744327 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT00974285 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT01573637 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT01573637 — Predictive Biomarker (PRD); Safety Biomarker (SAF): ESR2 mRNA
Genes: ESR2; ESTRB; NR3A2
Study NCT03726515 — Predictive Biomarker (PRD): O-6-methylguanine-DNA-alkyltransferase
Genes: MGMT
Study NCT02839902 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT02574871 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02616393 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT02616393 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT02582853 — Safety Biomarker (SAF): Hemoglobin scavenger receptor
Genes: CD163; M130
Study NCT04283565 — Predictive Biomarker (PRD): BPI mRNA
Genes: BPI
Study NCT04283565 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02738684 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT01904708 — Surrogate Endpoint (SUR): Plasma phenylalanine
Study NCT02741570 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study NCT00963339 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study NCT03857087 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT04267731 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT04533399 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT03832569 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT02611895 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT04412694 — Surrogate Endpoint (SUR): Serum calcium
Study NCT02507414 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT00401765 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT04589013 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT04589013 — Safety Biomarker (SAF): Hemoglobin scavenger receptor
Genes: CD163; M130
Study NCT04589013 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT04589013 — Predictive Biomarker (PRD): ROS1 mRNA
Genes: ROS1; MCF3; ROS
Study NCT04589013 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT02610491 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01909882 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04268875 — Predictive Biomarker (PRD); Safety Biomarker (SAF): DES mRNA
Genes: DES
Study NCT04086797 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00458042 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study NCT02202460 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study NCT06321874 — Predictive Biomarker (PRD): EPX mRNA
Genes: EPX; EPER; EPO; EPP
Study NCT00016367 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT02104271 — Predictive Biomarker (PRD): APC mRNA
Genes: APC; DP2.5
Study NCT00476489 — Predictive Biomarker (PRD): POMC
Genes: MSH; POC; CLIP; ACTH; NPP; LPH
Study NCT03454516 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01807052 — Predictive Biomarker (PRD): TF mRNA
Genes: TF; PRO1400
Study NCT00125866 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03000543 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT04102553 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT00098722 — Predictive Biomarker (PRD): CCR5 mRNA
Genes: CCR5; CMKBR5
Study NCT01611051 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT02885155 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study NCT01342965 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT01342965 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT00681980 — Pharmacodynamic Biomarker (PDY): Valproic acid
Study NCT02151448 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-X-C motif chemokine 10
Genes: CXCL10; INP10; SCYB10
Study NCT01073865 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT01914484 — Predictive Biomarker (PRD): BCR mRNA
Genes: BCR; BCR1; D22S11
Study NCT01914484 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase ABL1
Genes: ABL1; ABL; JTK7
Study NCT01358123 — Safety Biomarker (SAF): von Willebrand factor
Genes: VWF; F8VWF
Study NCT01494610 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01852825 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Immunoglobulin E
Study NCT03081676 — Pharmacodynamic Biomarker (PDY): Gastric inhibitory polypeptide
Genes: GIP
Study NCT03081676 — Predictive Biomarker (PRD): HNF1A mRNA
Genes: HNF1A; TCF1
Study NCT01765426 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT00808535 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT00541840 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT00541840 — Predictive Biomarker (PRD): PDGFRB mRNA
Genes: PDGFRB; PDGFR; PDGFR1
Study NCT00541840 — Predictive Biomarker (PRD): RAF1 mRNA
Genes: RAF1; RAF
Study NCT00949624 — Predictive Biomarker (PRD): PDGFRB mRNA
Genes: PDGFRB; PDGFR; PDGFR1
Study NCT00949624 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT00949624 — Predictive Biomarker (PRD): VEGF
Genes: VEGFA; VEGF-A; VPF
Study NCT00949624 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT02733510 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT02888327 — Safety Biomarker (SAF): SLCO1B1
Genes: OATP-C; LST-1; OATP1B1
Study NCT04594850 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study NCT04552366 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT00409383 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Lactate dehydrogenase
Study NCT01248858 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PIK3CA
Genes: PI3K
Study NCT00000558 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT02460770 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study NCT04054492 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT04922931 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT06235762 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01237262 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT01093781 — Pharmacodynamic Biomarker (PDY): Angiotensinogenase renin
Genes: REN
Study NCT01093781 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00327574 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01667562 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT01667562 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT01339390 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01224639 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT00404170 — Safety Biomarker (SAF): SLC6A3
Genes: DAT
Study NCT02812667 — Predictive Biomarker (PRD): BPI mRNA
Genes: BPI
Study NCT01113489 — Predictive Biomarker (PRD): Interleukin 5
Genes: IL5
Study NCT01113489 — Predictive Biomarker (PRD): Exhaled nitric oxide
Study NCT01420627 — Monitoring Biomarker (MOI): Adenosine deaminase
Genes: ADA; ADA1
Study NCT03029546 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT03029546 — Predictive Biomarker (PRD): AGER mRNA
Genes: AGER; RAGE
Study NCT00787137 — Predictive Biomarker (PRD): CD40 mRNA
Genes: CD40; TNFRSF5
Study NCT02761694 — Predictive Biomarker (PRD): PIK3CA mRNA
Genes: PIK3CA
Study NCT02761694 — Predictive Biomarker (PRD): Phosphatase and tensin homolog
Genes: PTEN; MMAC1; TEP1
Study NCT02761694 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PIK3CA
Genes: PI3K
Study NCT02513823 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03740789 — Monitoring Biomarker (MOI): HBV DNA
Study NCT00319657 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT04214886 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT04214886 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT02958839 — Pharmacodynamic Biomarker (PDY): Fibroblast growth factor 23
Genes: FGF23; HYPF; UNQ3027/PRO9828
Study NCT00849368 — Safety Biomarker (SAF): Thiopurine S-methyltransferase
Genes: TPMT
Study NCT03696654 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03202862 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT03202862 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT03202862 — Predictive Biomarker (PRD): Hormone receptor
Study NCT03417388 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT00107458 — Pharmacodynamic Biomarker (PDY): Valproic acid
Study NCT04082910 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT01453842 — Predictive Biomarker (PRD): GPR119 mRNA
Genes: GPR119
Study NCT04175093 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT02273843 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT02273843 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT02273843 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT02203864 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT02439112 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT02889094 — Monitoring Biomarker (MOI): HBV DNA
Study NCT04933591 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-C motif chemokine 2
Genes: CCL2; MCP1; SCYA2
Study NCT04248569 — Predictive Biomarker (PRD): DNAJB1 mRNA
Genes: DNAJB1; DNAJ1; HDJ1; HSPF1
Study NCT04248569 — Predictive Biomarker (PRD): PRKACA mRNA
Genes: PRKACA; PKACA
Study NCT00749775 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02487394 — Predictive Biomarker (PRD): ARCN1 mRNA
Genes: ARCN1; COPD
Study NCT00953329 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT00477269 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study NCT01768611 — Predictive Biomarker (PRD): SLC2A1 mRNA
Genes: SLC2A1; GLUT1
Study NCT00499096 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04013620 — Safety Biomarker (SAF): Cytotoxic T-lymphocyte protein 4
Genes: CTLA4; CD152
Study NCT04013620 — Predictive Biomarker (PRD): CD28 mRNA
Genes: CD28
Study NCT02997033 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT03783104 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study NCT04058704 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT04058704 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT01417117 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01883401 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01883401 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT00499603 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PIK3CA
Genes: PI3K
Study NCT00499603 — Predictive Biomarker (PRD): Phosphatase and tensin homolog
Genes: PTEN; MMAC1; TEP1
Study NCT03738007 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT02885623 — Predictive Biomarker (PRD): CX3CR1 mRNA
Genes: CX3CR1; CMKBRL1; GPR13
Study NCT02885623 — Predictive Biomarker (PRD): CX3CL1 mRNA
Genes: CX3CL1; FKN; NTT; SCYD1; A-152E5.2
Study NCT02437786 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT01231815 — Predictive Biomarker (PRD); Safety Biomarker (SAF): CAV1 mRNA
Genes: CAV1; CAV
Study NCT00404352 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study NCT00233727 — Surrogate Endpoint (SUR): Cervical intraepithelial neoplasia
Study NCT02857192 — Predictive Biomarker (PRD): ENTPD1 mRNA
Genes: ENTPD1; CD39
Study NCT02688088 — Predictive Biomarker (PRD): CYP2C9 mRNA
Genes: CYP2C9; CYP2C10
Study NCT02688088 — Safety Biomarker (SAF): Cytochrome P450 2D6
Genes: CYP2D6; CYP2DL1
Study NCT00099463 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT02703571 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT00317616 — Predictive Biomarker (PRD): IGFALS mRNA
Genes: IGFALS; ALS
Study NCT03627728 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT01838785 — Predictive Biomarker (PRD); Safety Biomarker (SAF): SLC18A2 mRNA
Genes: SLC18A2; SVMT; VMAT2
Study NCT02242357 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04106310 — Safety Biomarker (SAF): Beta-2-microglobulin
Genes: B2M; CDABP0092; HDCMA22P
Study NCT04106310 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT04106310 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT04489706 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Cellular tumor antigen p53
Genes: TP53; P53
Study NCT03562819 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT03562819 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT03919461 — Predictive Biomarker (PRD); Safety Biomarker (SAF): COX2 mRNA
Genes: PTGS2; COX2
Study NCT04425330 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study NCT01098877 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): CCR2 mRNA
Genes: CCR2; CMKBR2
Study NCT01098877 — Predictive Biomarker (PRD): CCR5 mRNA
Genes: CCR5; CMKBR5
Study NCT03287674 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT05792644 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT05985213 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04609800 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT04609800 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT03671408 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT01752400 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT02119546 — Predictive Biomarker (PRD): Apolipoprotein E
Genes: APOE
Study NCT04185168 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02248090 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT02248090 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT00490165 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT03393793 — Predictive Biomarker (PRD): ACR mRNA
Genes: ACR; ACRS
Study NCT03393793 — Predictive Biomarker (PRD); Safety Biomarker (SAF): CAV1 mRNA
Genes: CAV1; CAV
Study NCT00682513 — Predictive Biomarker (PRD): ATP1A3 mRNA
Genes: ATP1A3
Study NCT01980277 — Predictive Biomarker (PRD): PI3 mRNA
Genes: PI3; WAP3; WFDC14
Study NCT01980277 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PIK3CA
Genes: PI3K
Study NCT00364780 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT00364780 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor receptor 2
Genes: KDR; FLK1; VEGFR2
Study NCT01074333 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT01074333 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT01074333 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT00974714 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02201303 — Predictive Biomarker (PRD); Safety Biomarker (SAF): CXCL1 mRNA
Genes: CXCL1; GRO; GRO1; GROA; MGSA; SCYB1
Study NCT00009919 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT02099214 — Predictive Biomarker (PRD): HFE mRNA
Genes: HFE; HLAH
Study NCT03869593 — Predictive Biomarker (PRD): NLRP3 mRNA
Genes: NLRP3; C1orf7; CIAS1; NALP3; PYPAF1
Study NCT00557791 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT05512676 — Predictive Biomarker (PRD): TBXT mRNA
Genes: TBXT; T
Study NCT02516826 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01574352 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01176552 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT01176552 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT01027091 — Surrogate Endpoint (SUR): Serum calcium
Study NCT03651791 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study NCT02774681 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL